CNASHighly Regulated (List I)TranslatedELIGARD
RACORDATI INDUSTRIA CHIMICA E FARMACEUTICA
Identification
- Active ingredient (INN)
- LEUPRORELINE ACETATE
- Internal code
- 05 E 172
- Country of Origin
- Italy
- Pharmaceutical form
- Powder + Solvent for SC Inj. (6-month)
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/01kit de 2 plateaux thermoformes contenant : (01 sering. preremp. d. solv. (sering. a) + 01 piston a tige longue) + (01 sering. preremp. d. pdre. (sering. b) + 01 aiguille sterile 18g)
CNASDAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Advanced prostate cancer is treated for anemia intrauterine abdominal abdominal abdominal abdominal abdominal abdominality.
Associated Conditions
Treatment may cause a decrease in bone density (bone fragility) in women, some patients may need food supplements or medication to prevent supply.
Separate cases of spinal cord compression and septical blockages among men with prostate cancer after they have received treatment are reported; patients are better monitored and any new symptoms are observed, especially in the first weeks of treatment.
Mechanism of Action
Leprolid discourages the release of bludgeoned hormones and papyramones from the pituitary gland, which leads to a severe drop in the testosterone, known for its activation of cancer tissue.
Do you have questions on this subject? Ask Sina, artificial intelligence to answer all your medical questions, write your question here, Sina, prepare the answer for you.